Skip to main content

Table 3 Distribution by farm of bacterial pathogens isolated before treatment on day 0 from lower respiratory tract lesions and bronchoalveolar lavage samples, and ranges of minimum inhibitory concentrations (MIC) of marbofloxacin and enrofloxacin

From: Randomised controlled field study to evaluate the efficacy and clinical safety of a single 8 mg/kg injectable dose of marbofloxacin compared with one or two doses of 7.5 mg/kg injectable enrofloxacin for the treatment of Actinobacillus pleuropneumoniae infections in growing-fattening pigs in Europe

  

MIC range (μg/mL)

Farm site

Marbofloxacin

Enrofloxacin

n

A. pleuropneumoniae

GA

0.03–0.06

0.06–0.12

9

GB

0.03–0.25

0.03–0.25

9

HA

0.06–0.12

0.06–0.12

18

HB

0.03–0.06

0.03–0.06

25

H. somnus

GA

–

–

0

GB

0.015

0.008

1

HA

–

–

0

HB

0.03

0.03

1

P. multocida

GA

–

–

0

GB

0.015

0.008

1

HA

0.015–0.03

0.008

7

HB

–

–

0

B. bronchiseptica

GA

0.5

0.5

4

GB

0.25–0.5

0.25–0.5

4

HA

–

–

0

HB

0.25

0.5

1

  1. Farm site: Country identification G Germany, H Hungary. A and B indicate different farms within country
  2. MIC concentrations ranges (μg/mL) of the antimicrobial for which all of the isolates were inhibited
  3. n total number of isolates from lung/lower respiratory tract and bronchoalveolar lavage, combined, for which MIC was determined
Back to article page

Porcine Health Management

ISSN: 2055-5660

Contact us